In "Has the time come to legalize drugs?" Andres Oppenheimer, the influential opinion maker about Latin American affairs at the Miami Herald, describes how the debate about cannabis regulation "is rapidly moving to the mainstream in Latin America." He quotes White House drug czar Kerlikowske who argues that The Netherlands proves that relaxation of cannabis laws increases consumption, and that the Dutch government is now reversing its strategy. That requires some rectification.
On Nov. 2, Californians will vote on Proposition 19, deciding whether to legalize the production, sale and consumption of marijuana. If the initiative passes, it won't just be momentous for California; it may, at long last, offer Mexico the promise of an exit from our costly war on drugs. The costs of that war have long since reached intolerable levels: more than 28,000 of our fellow citizens dead since late 2006; expenditures well above $10 billion; terrible damage to Mexico's image abroad; human rights violations by government security forces; and ever more crime.
The CATO report estimates that legalizing drugs would save roughly $41.3 billion per year in government expenditure on enforcement of prohibition. Of these savings, $25.7 billion would accrue to state and local governments, while $15.6 billion would accrue to the federal government. Approximately $8.7 billion of the savings would result from legalization of marijuana and $32.6 billion from legalization of other drugs.
The report reviews 20 years of data from US government funded surveillance systems on government drug control spending, cannabis seizures and cannabis arrests, in order to assess the impact of enforced cannabis prohibition on cannabis potency, price and availability. The report’s findings highlight the clear failure of cannabis prohibition efforts by showing that as the United States has dramatically scaled up drug law enforcement, cannabis potency has nevertheless increased, prices have dropped, and cannabis remains widely available.